showing any preferential association with bone marrow subcompartments. Unexpectedly, this behaviour was maintained throughout disease development, from the earliest bone marrow seeding to response and resistance to chemotherapy. Our results reveal that T-ALL cells do not depend on specific bone marrow microenvironments for propagation of disease, nor for the selection of chemo-resistant clones, suggesting that a stochastic mechanism underlies these processes. Yet, although T-ALL infiltration and progression are independent of the stroma, accumulated disease burden leads to rapid, selective remodelling of the endosteal space, resulting in a complete loss of mature osteoblastic cells while perivascular cells are maintained. This outcome leads to a shift in the balance of endogenous bone marrow stroma, towards a composition associated with less efficient haematopoietic stem cell function 1 . This novel, dynamic analysis of T-ALL interactions with the bone marrow microenvironment in vivo, supported by evidence from human T-ALL samples, highlights that future therapeutic interventions should target the migration and promiscuous interactions of cancer cells with the surrounding microenvironment, rather than specific bone marrow stroma, to combat the invasion by and survival of chemo-resistant T-ALL cells.
therefore it is critical that we understand both the spatial and kinetic nature of leukaemia-BM interactions. However, our current knowledge of leukaemia biology is predominantly derived from ex vivo flow cytometric analysis, and static images that cannot capture information on the location and dynamics of leukaemia interactions with BM structures and cells over time.
We studied a Notch-driven mouse model of T-ALL, which recapitulates human disease both phenotypically (Extended Data Fig. 1 ) and genetically 11, 12 . Twenty-five per cent of paediatric and 40% of adult T-ALL patients develop aggressive relapsed disease originating from chemo-resistant clones 13 . Thus, there is a pressing need to understand if T-ALL cells migrate to, and interact with particular BM stroma during the propagation of disease and/or selection of chemo-resistance, or if T-ALL can remodel the BM microenvironment in its favour.
To address these questions, we monitored leukaemia growth in mouse calvarium bone marrow by intravital microscopy [14] [15] [16] . We used a tile-based imaging approach that allows tissue-wide visualization of heterogeneous BM microenvironments ( Fig. 1a, b) while maintaining a resolution that permits the measurement of single leukaemia cell interactions with BM cells and structures by time-lapse microscopy 15 ( Fig. 1c and Supplementary Video 1). To characterize T-ALL interactions systematically in vivo, we injected transformed leukaemic cells isolated from primary hosts into secondary recipients, and observed highly synchronous disease progression ( Fig. 1d and Extended Data Fig. 1 ). In secondary recipients, T-ALL preferentially infiltrated the BM before expansion to peripheral lymphoid organs (Extended Data Fig. 1 ). This is consistent with expression of CXCR4, albeit at variable levels, on leukaemic cells (Extended Data Fig. 1 ). We visualized T-ALL cells relative to osteoblasts (green fluorescent protein (GFP) or cyan fluorescent protein (CFP) positive in Col2.3-GFP/CFP reporter mice 17, 18 ), perivascular mesenchymal stem/progenitor cells (GFP positive in nestin-GFP reporter mice 19 ) and vasculature (by injecting Cy5 dextran) in cohorts of recipient mice during disease progression and treatment (Fig. 1d ).
By day 10 after transplantation we could reproducibly observe single, sparse T-ALL cells in the BM at a frequency of 1-30 cells per calvarium ( Fig. 1e, f) . We measured the proximity of leukaemia cells to osteoblastic and nestin-GFP + cells and vasculature. We used randomly positioned dots as a control for the specificity of observed associations, as these do not possess any inherent ability to localize to a particular BM stroma component (Fig. 1g ). The distribution of T-ALL cells was equivalent to that of the random dots and the actual distances recorded inversely correlated with the abundance of each component ( Fig. 1h-j) . These results demonstrate that seeding T-ALL in the BM is stochastically distributed relative to osteoblasts, nestin-GFP + cells and vasculature.
To determine whether T-ALL expansion was supported by specific constituents of the BM, we monitored the dynamics of single T-ALL cells ( Fig. 2a ) for 3 h (Fig. 2b , c, Extended Data Fig. 2 and Supplementary Videos 2, 3). This revealed that the vast majority of T-ALL cells were motile, in stark contrast with previous observations of transplanted haematopoietic stem cells in BM 15 , and that movement was rarely restricted to the proximity of any specific cell types or structures ( Fig. 2b , c, position 2 and 3, and Supplementary Videos 2, 3). Notably, the speed of any given cell over time was also heterogeneous, and thus no single migratory behaviour was associated with osteoblastic, nestin-GFP + cells or vasculature ( Fig. 2c , Extended Data Fig. 2 and Supplementary Videos 2, 3). Tracking single T-ALL cells enabled us to measure the location of mitotic events, revealing the same stochastic distribution of dividing cells and suggesting that proximity to these stroma components is not key for T-ALL expansion ( Fig. 2d , e, Extended Data Fig. 2 and Supplementary Videos 2, 3). Additionally, daughter cells migrated large distances after division, illustrating that clones and their progeny are not restricted to foci within the local microenvironment ( Fig. 2c and Supplementary Video 2, position 3). These observations were consistent with tile scans performed at later stages of BM colonization (day 12-18 after transplantation), where we detected pockets of high and low infiltration juxtaposed in all types of microenvironments (Extended Data Figs 3 and 4). Interestingly, the motility patterns displayed by single, isolated cells were also consistently observed when tracking individual cells located in densely infiltrated areas (Supplementary Video 4). Combined, these analyses demonstrate that T-ALL seeding and colonization of BM do not select for, or depend on specific BM stroma.
The question remained whether certain BM regions could create 'hotspots' for chemo-resistance through provision of a protective environment. To address this issue, we adapted our imaging protocol to follow the same BM areas over multiple days to track leukaemia dynamics from complete BM infiltration and throughout therapy. We used the lock-and-key mechanism of the imaging window to re-position mice precisely on the microscope stage over multiple imaging sessions. Mice were tile scanned 18 days after T-ALL transplantation to confirm full BM infiltration. Dexamethasone was then administered daily ( Fig. 3a) , and immediately after the third therapy dose we observed a staggering reduction in disease burden 20 (Fig. 3b-d and Extended Data Fig. 5a , b), while non-leukaemic, dexamethasone-treated control mice maintained robust BM and stroma cellularity (Extended Data Fig. 5d , e). Strikingly, surviving cells were scattered throughout the BM space and not preferentially associated with osteoblastic, nestin-GFP + cells or vasculature compared with simulated data ( To test whether initial T-ALL loss was independent from specific stroma components, we increased the imaging temporal resolution to include the first day of treatment. The distribution of T-ALL cells was maintained as disease gradually succumbed to therapy (Extended Data Fig. 6 ). In contrast to predictions based on previous publications 3, 9, 10 , time-lapse imaging immediately after administration of the third dose of dexamethasone demonstrated that single surviving cells were highly migratory and did not maintain long-lasting associations with osteoblastic ( Fig. 3g, h and Supplementary Video 5) or nestin-GFP + cells (Supplementary Video 6). Furthermore, surviving cells travelled at significantly faster speeds than early infiltrating cells (days 10-15) ( Fig. 3m ). Finally, residual T-ALL cells were still capable of undergoing division ( Fig. 3g and Supplementary Videos 5, 6) at times when other cells within the same mouse were still undergoing death (Supplementary Video 6). This behaviour, coupled with the observation that mice maintained on dexamethasone for a 7-day period harboured an almost completely repopulated BM space (Extended Data Fig. 7a ), suggests that these cells were genuinely resistant to dexamethasone.
Collectively, these data contradict the prevailing hypothesis that therapyresistant leukaemic cells depend on a particular microenvironment letter reSeArCH
for survival. To investigate this proposed paradigm, we compared the gene expression profile of T-ALL cells purified at full infiltration to those isolated from mice 7-10 days after initiation of dexamethasone treatment, when surviving cells have re-colonized the BM (Extended Data Fig. 7a ). Gene expression profiles of all T-ALL samples were more heterogeneous compared with control T cells (CD4 + and CD8 + ), T-cell progenitor (CD4 + CD8 + thymocytes) and whole BM populations, as expected on the basis of inter-clone variation in leukaemia cells 21 . The transcriptome of resistant cells overlapped with that of T-ALL cells pre-treatment (Extended Data Fig. 7c ). Indeed, only 79 genes were differentially expressed in the post-treatment group and, consistent with our intravital imaging data, none of the differentially expressed genes were related to known cell-niche interaction candidates (Supplementary Table 1 and Extended Data Fig. 7b ). Together, our imaging and gene expression data suggest that dexamethasone treatment does not select for a subpopulation of T-ALL cells that have been directed to a specific niche.
To investigate the importance of these data in a human context, we assessed the migratory behaviour of xenotransplanted primary human T-ALL (Supplementary Table 2 ) in NOD/SCID/γ mice. After dexamethasone treatment, even human wild-type NOTCH receptor T-ALL cells exhibited migratory behaviour equivalent to murine cells (Extended Data Fig. 8a-d and Supplementary Video 7). We noted an even distribution of quiescent cells throughout the BM as measured by Ki-67 staining (Extended Data Fig. 8e, f) . To test whether the migratory behaviour was a specific trait induced by dexamethasone, we treated murine T-ALL burdened animals with vincristine.
The T-ALL response followed similar kinetics to that of dexamethasone-treated animals. Enhanced migration of resistant cells and cell division events were evident immediately after the third dose of vincristine ( Fig. 3i , j, m and Supplementary Video 8). This behaviour was even more pronounced when we combined dexamethasone, vincristine and l-asparaginase ( Fig. 3k -m, Extended Data Fig. 9 and Supplementary Video 9). In this context, we observed the highest migration speed of all therapies tested, despite over 50% of surviving cells being in G0 (Fig. 3n, o) , demonstrating that quiescence is not a feature of niche-restricted immotile cells after chemotherapy. These findings were universal in all therapies tested in our studies, suggesting that migration and lack of long-lasting interactions with the surrounding microenvironment are conserved features of chemo-resistance in T-ALL.
To assay whether T-ALL may affect BM structures, we performed time-lapse imaging in heavily disease-burdened, untreated mice. After day 18 we observed striking remodelling of osteoblasts ( Fig. 4a, b) . A 9 h period of time-lapse imaging after full infiltration (day 19 onwards) revealed that osteoblastic cells underwent dramatic shrinking and blebbing ( Fig. 4a and Supplementary Video 10), in stark contrast to the early stages of disease (Supplementary Video 1) and to control Col2.3-GFP mice reconstituted with red fluorescent healthy BM, where osteoblastic cells were unaffected ( Fig. 4a, b , Extended Data Fig. 10a, b and Supplementary Video 10). TdTmediated dUTP nick end labelling (TUNEL) and cleaved caspase-3 histological stainings indicated that osteoblasts were undergoing apoptosis (Fig. 4c ). The loss of osteoblasts was so dramatic that virtually no GFP + osteoblasts remained apparent by days 22-25 after transplantation (Fig. 4b, d ). Similar results were also found for osterix + osteo-progenitors (Fig. 4f) ; however, nestin-GFP + cells were maintained ( Fig. 4e and Extended Data Fig. 10c, d) , and blood vessels could still be visualized (Extended Data Fig. 10e ). Importantly, these findings were consistent in analyses performed using human T-ALL samples ( Supplementary Table 2 ). We observed a significant reduction in osterix + osteo-progenitors in NOD/SCID/γ recipient mice xenotransplanted with human T-ALL samples (Fig. 4f ). Additionally, histological analysis of BM trephine biopsies from T-ALL patients with greater than 75% infiltration demonstrated an almost complete loss of osteoblasts (Fig. 4g ).
We demonstrate that T-ALL infiltrates the BM and survives chemotherapy independently of stable interactions with specific microenvironments. However, T-ALL has a profound effect on osteoblastic cells. Our results suggest that to avoid the development of chemo-resistance, novel therapeutic interventions may not need to target specific BM stroma components, but rather the ability of T-ALL cells to interact with and migrate through the BM. Our studies also reveal that T-ALL has the intrinsic potential to remodel the BM microenvironment via apoptosis throughout the osteolineage. As these cells are associated with haematopoietic fitness 14, 22, 23 , including in the context of leukaemia 1, 2, 24 , the remodelling we uncovered may contribute to the loss of healthy haematopoiesis observed in leukaemia patients 1, 2 . Collectively, our observations suggest that a shift in therapeutic design may be advisable, such that any intervention targeting osteoblastic cells should focus on promoting survival of this lineage, rather than seeking to modulate a direct influence of the BM on the cancer itself. Therefore, a better focus for novel anti-cancer therapeutics may be on disrupting the ability of T-ALL cells to interact transiently with multiple components of the BM microenvironment. Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. letter reSeArCH MethOdS Mice. All animal experimentation in this study was approved and performed according to the standards of the animal ethics committee at Imperial College London and to UK Home Office regulations (ASPA 1986). C57Bl/6 mice were purchased from Harlan UK Ltd; Col2.3-GFP, Col2.3-CFP 18 , nestin-GFP and mTmG 25 mice were bred and housed at Imperial College London. For imaging experiments, female Col2.3-GFP and nestin-GFP mice >8 weeks old were used. osterix-CreGFP mice were provided by A. McMahon and backcrossed over eight generations into NSG mice and maintained at the Francis Crick Institute, Cancer Research UK 26 . Equal proportions of male and female osterix-CreGFP mice aged 11-14 weeks were used. Generation of murine T-ALL disease. T-ALL was generated as previously described 27 . Briefly, timed matings were established between C57Bl/6 mice and embryos harvested at E14.5. Single-cell suspensions were prepared from whole fetal livers isolated from the embryos. Suspensions were cultured in IL-3, IL-6, and stem cell factor conditioned media with 20% FCS for 3 days. Lin-xE cells were transfected by calcium phosphate with MigR1 plasmids containing either DsRed only or DsRed with NotchICNΔRamΔP as described previously 28 . We also used GFP-tagged plasmids when required. Supernatants containing recombinant retrovirus were removed and spun by centrifugation onto non-tissueculture-treated plates coated with 15 μg/ml retronectin (Takara Clontech, CA). Fetal liver cells were cultured in the presence of virus for 3 days and transduction was assessed by flow cytometry. Primary lethally irradiated recipient mice (two doses of 5.5 Gy administered greater than three hours apart) were transplanted with 1 × 10 6 DsRed + fetal liver cells by intravenous injection into the tail vein. Recipient mice were maintained on baytril-treated water to prevent infection for >6 weeks post-transplantation. Cohorts of reconstituted mice were the result of three independent fetal liver isolations and three independent transfections. Transformation of Notch-transduced non-malignant cells is highly heterogeneous in vivo, with onset of primary disease ranging from 6-25 weeks 28 (Extended Data Fig. 1 ). More than 4 weeks post-reconstitution, peripheral blood was isolated from mice, red blood cells were lysed, and successful reconstitution determined by presence of DsRed + cells. Mice reconstituted with NotchICNΔRamΔP-transduced fetal livers were monitored daily for signs of leukaemia onset or other signs of ill health. Mice were euthanized when any one or a combination of the following signs were observed: hunched posture, laboured breathing, weight loss, enlarged lymph nodes and/or spleen, peripheral white blood cell cellularity of 13 × 10 9 per litre or greater. No experiment exceeded the tumour burden approved by the Home Office and Imperial College ethics committee. Peripheral lymphoid organs were analysed by flow cytometry for DsRed or GFP, CXCR4, CD3, CD4 and CD8 expression. All FACS data was collected on a Fortessa flow cytometer (BD Biosciences, CA). Secondary recipients were sub-lethally irradiated (two doses of 3 Gy administered greater than three hours apart) and injected with 10,000 thawed, Ficoll purified T-ALL blasts and monitored as described earlier. In selected cases 10,000 secondary T-ALL cells were transplanted into tertiary recipients. For therapy experiments, mice were injected i.v. daily with 15 mg/kg dexamethasone sodium phosphate 29, 30 (Sellekchem, MA) alone, 0.15 mg/kg vincristine sulfate salt (Sigma) alone or with a combination of 15 mg/kg dexamethasone, 0.15 mg/kg vincristine and 1,000 IU/ kg l-asparaginase (medac; obtained from the Imperial College Healthcare NHS Trust Pharmacy). Bone marrow chimaeras. Reconstitution with MigR1 DsRed-transduced cells yields <50% chimaerism. For this reason, analysis of healthy BM cells by microscopy is inaccurate. Therefore, to obtain >95% chimaerism of healthy, red fluorescent BM to be used for imaging control experiments, whole BM mononuclear cells were isolated from femurs, hips and tibia of mTmG donor mice, suspended in phosphate balanced salt solution and administered intravenously to recipient mice at a dose of 2 × 10 6 cells/mouse. Recipient Col2.3-GFP or C57Bl/6 mice had been lethally irradiated (two doses of 5.5 Gy irradiation greater than 3 h apart) immediately before the transplant, and were maintained on baytril-treated water to prevent infection >6 weeks post-transplantation. Intravital microscopy. Intravital microscopy was performed using a Leica SP5 and a Zeiss LSM 780 upright confocal microscope with a motorized stage. The SP5 was fitted with the following lasers: Argon, 546, 633 and a tunable infrared multiphoton laser (Spectraphysics Mai Tai 690-1020). The Zeiss LSM 780 was fitted with the following lasers: Argon, 561, 633 and a tunable infrared multiphoton laser (Spectraphysics Mai Tai DeepSee 690-1040). Signal was visualized with a Leica HCX IRAPO L ×25 water immersion lens (0.95 N.A) and a W Plan-Apochromat ×20 DIC water immersion lens (1.0 N.A). Collagen bone second harmonic generation signal and GFP and CFP signals were generated through excitation at 840 and 870 nm and detected with external detectors. Internal detectors were used to collect DsRed and Cy5 signal (and on some occasions, GFP). Prior to surgery, mice were administered analgesia with buprenorphine (0.1 mg/kg intraperitoneally (i.p.)).
Anaesthesia was induced in mice with 4% isoflurane mixed with pure oxygen. This was gradually reduced to approximately 1% as anaesthesia stabilized. Surgery to attach the headpiece was then performed as described previously 16 . Large threedimensional 'tile scans' of the entire BM cavity space were acquired by stitching adjacent, high-resolution z-stack images using a surgically implanted imaging window that ensures steady positioning of mice on the microscope. The calvarium has been demonstrated to be equivalent to the long bones such as the femur with regards to haematopoietic stem cell frequency, function and localization 14, 22 , and is the only BM compartment that allows longitudinal imaging through minimally invasive surgery 16, 31 . Blood vessels were highlighted by i.v. injection of 50 μl of 8 mg/ml 500 kDa Cy5-Dextran (Nanocs, MA). Cy5-Dextran was re-injected every 1-2 h to maintain blood vessel signal and cross reference for registration of blood vessel data in time-lapse analysis. For repeated imaging, protective intrasite gel (Smith & Nephew) was applied to the imaging window to preserve the bone integrity and prevent scar formation. The window was bandaged, and mice were allowed to recover from anaesthesia. Owing to the lock-and-key mechanism of the imaging window 16 , mice could then be re-anaesthetized and accurately repositioned on the microscope stage and the same BM areas re-imaged. After each imaging, analgesia was administered via oral buprenorphine in raspberry jelly at a dose of approximately 0.8 mg/kg. Image quantification. Microscopy data was processed using multiple platforms. Tile scans were stitched using Leica Application Systems (LAS; Leica Microsystems, Germany) and ZEN black (Zeiss, Germany) softwares. Raw data were visualized and processed using Fiji/Image J. Simulated data was prepared using FIJI macros to create, and overlay z-stack images on original tile-scan data. Using the internal random number algorithm, spheres matching the size of T-ALL cells (11-15 μm) were placed at random x,y,z coordinates. Simulated data FIJI macro is available on request. Automated cell segmentation, distance and volume measurements were performed in Definiens (Definiens Developer 64, Germany) using local heterogeneity segmentation 32 to isolate osteoblast and nestin cells as well as vasculature, and a combination of seed detection algorithm and morphological growing and shrinking operations to detect leukaemia cells. Definiens rulesets for these functions are available upon request. Distance measurements from this segmentation were performed as described previously 32 . Cell tracking was performed using Imaris (Bitplane, Switzerland) and the FIJI plugin MTrackJ. For accuracy in cell tracking data, videos were registered when required before using four-dimensional data protocols implemented in Fiji 33 . Three-dimensional data rendering and measurement of cell division distances were performed in Volocity (Perkin Elmer, MA) and Definiens (Definiens Developer 64, Germany). Microarrays. T-ALL samples were harvested from bone marrow and FACS sorted based on fluorescent protein expression (DsRed or GFP) unless infiltration of bone marrow was complete. Control samples for microarray were prepared by FACS sorting for splenic CD4 + T cells, CD8 + T cells and CD4 + CD8 + thymocytes from 8-14-week female C57Bl/6 mice. RNA was purified from samples using the Qiagen RNeasy mini kit (Netherlands) as per the manufacturer's instructions. Purified RNA was prepared for hybridization using the Genechip WT Plus reagent kit (Affymetrix, CA) as per the manufacturer's instructions and hybridized with genechip Mouse gene 2.0 ST array (Affymetrix, CA) by the MRC Genomics Facility (Imperial College London). Analysis was performed using R version 3.1.1. Data were normalized and summarized to 'core' level using the RMA method from the oligo package (version 1.30.0) 34 . Annotation was downloaded from the Affymetrix NetAffx Query website. Differential expression was determined using limma version 3.22.7 (ref. 35) . Genes with Benjamini-Hochberg-adjusted P value < 0.05 and absolute log-fold-change >1 were deemed significant. Heatmaps of gene expression were generated with pheatmap package version 1.0.2.
Human T-ALL xenografts. Primary human T-ALL samples were obtained from Barts Hospital (London) after informed consent via a protocol approved by the East London Research Ethics Committee and carried out in accordance with the principles of the Helsinki declaration (see Supplementary Table 2 for details), before treatment being administered to the patients. Primary cells from two distinct patients were immunophenotyped, and CD45 + /CD7 + /CD4 −/low /CD8 −/low cells sorted and infused i.v. in non-conditioned osterix-CreGFP/NOD/SCID/γ recipient mice. Primary xenograft transplantation was assessed via peripheral blood sampling and/or BM aspiration. BM and spleen-derived primary xenografts were infused i.v. in non-conditioned NOD/SCID/γ secondary recipient mice for therapy experiments. Intravital imaging was performed as described earlier. Human T-ALL cells were labelled by injecting 10 μg of PE-conjugated human CD45 antibody (clone HI30, Biolegend) 15-30 min before the imaging session. For dexamethasone therapy experiments, mice were treated with daily injections of 15 mg/kg i.v. 30 . Number of human T-ALL cells in therapy experiments was quantified using reference beads as described previously 36 .
letter reSeArCH
Immunofluorescence. Hips and tibias were harvested and post-fixed overnight in periodate-lysine-paraformaldehyde fixative, at 4 °C. Bones were then washed with 0.1 M phosphate buffer, cryoprotected in sucrose (10-30% gradient), for 48 h, frozen in optimal cutting temperature compound (TissueTek) and stored at −80 °C. Sections were cut in a Leica Cryostat, using the Cryojane tape transfer system (Leica Microsystems) and stored at −80 °C. For staining, slides were re-hydrated in PBS, permeabilized in 0.1% Triton X-100, blocked in 5% goat serum and incubated with primary antibodies overnight, at 4 °C. After washing in PBS, slides were incubated with secondary antibodies, counter-stained with DAPI (Invitrogen), washed in 0.1% Triton X-100 and mounted using Prolong Diamond antifade (Invitrogen). The following antibodies were used: Alexa Fluor 647 mouse anti-Ki-67 (B56, BD Biosciences, 1:50), PE-conjugated human CD45 antibody (HI30, BD Biosciences, 1:100), rabbit anti-cleaved caspase-3 (Asp175, Cell Signaling, 1:100), goat anti-rabbit IgG Alexa Fluor 633 (Life Technologies, 1:400). TUNEL labelling was performed to detect apoptotic cells, according to the manufacturer's instructions (DeadEnd Colorimetric TUNEL System, Promega). Images were obtained using a Zeiss LSM 780 upright confocal/two-photon combined microscope and analysed using Fiji/ImageJ. Cell counting was performed manually using the FIJI plugin Cell Counter. T-ALL cell number and cell cycle analysis. BM from human T-ALL xenotransplanted, untreated and treated mice was harvested and stained with DAPI (Invitrogen) and FITC mouse anti-Ki-67 set (BD Biosciences), according to the manufacturer's instructions. Cells were analysed by flow cytometry and absolute numbers were obtained using reference beads as described previously 36 . Osterix quantification. T-ALL engraftment and infiltration was confirmed via peripheral blood sampling and/or tibia puncture. Once mice presented with signs of ill health (as described earlier), mice were euthanized and bones were digested with a DNase I/Collagenase (Sigma) solution. The total number of Osx-GFP + cells was assessed by flow cytometry analysis using counting beads (CountBright, Life Technologies). Human trephine histology. Samples were obtained from patients after informed consent had been obtained, under full ethical approval by the Peter MacCallum Cancer Centre Human Research Ethics Committee. De-waxed human trephine biopsy sections (3 μM) were stained with osteocalcin antibody (Abcam ab93876, Cambridge), counterstained and mounted for viewing. All areas of each section were monitored for visible osteoblasts.
Statistics. The sample size required for the experiments was estimated based on the results of preliminary data. Blinding or randomization for animal experiments were not necessary due to the nature of the experiments. Statistical differences between the means of two data groups was determined by using two-tailed unpaired Student's t-test, and P values < 0.05 were considered significant. Multiple group comparisons were performed using ANOVA with a Bonferroni correction, P values < 0.05 were considered significant. 
